1621
|
|
|
Chromosome 5 open reading frame 22 |
- |
|
1622
|
|
|
Chromosome 5 open reading frame 24 |
- |
|
1623
|
|
|
Chromosome 5 open reading frame 47 |
- |
|
1624
|
|
|
Chromosome 5 open reading frame 52 |
- |
|
1625
|
|
|
Chromosome 5 open reading frame 58 |
- |
|
1626
|
|
|
Chromosome 5 open reading frame 63 |
YDR286C |
|
1627
|
|
|
Complement C6 |
- |
|
1628
|
|
|
Chromosome 6 open reading frame 118 |
bA85G2.1, dJ416F21.2 |
Alzheimer disease, Asthma, Astrocytoma, Attention deficit hyperactivity disorder, Bipolar disorder, Central nervous system cancer, Obstructive pulmonary disease, Rhinosinusitis, Color vision deficiency, Diabetic maculopathy, Endometriosis, Gastric cancer, Glioblastoma, Glioma, Insomnia, Major depressive disorder, Metabolic syndrome, Multiple myeloma, Obesity, Obsessive-compulsive disorder, Oligodendroglioma, Peptic ulcer disease, Pericarditis, Peripheral arterial disease, Psychiatric disorders, Schizophrenia, Scoliosis, Hypertension, Diabetes mellitus type 1, Diabetes mellitus type 2, Vascular dementiaView all (16 more) |
1629
|
|
|
Chromosome 6 open reading frame 132 |
LncCCLM, bA7K24.2 |
|
1630
|
|
|
Chromosome 6 open reading frame 15 |
STG |
Autoimmune neurological syndrome, Autism, Behcet disease, Celiac disease, Colorectal cancer, Crohn disease, Graves disease, Immune system disease, Inflammatory bowel disease, Leprosy, Lung cancer, Major depressive disorder, Membranous glomerulonephritis, Myasthenia gravis, Nasopharyngeal neoplasms, Neurotic disorder, Peripheral arterial disease, Prostate cancer, Psoriasis, Raynaud disease, Rheumatoid arthritis, Sarcoidosis, Schizophrenia, Small cell lung carcinoma, Squamous cell carcinoma, Thyrotoxic periodic paralysis, Diabetes mellitus type 1, Ulcerative colitisView all (13 more) |
